GetTopicDetailResponse(id=e514935e88, topicName=iclaprim, introduction=iclaprim, content=null, image=null, comments=2, allHits=1085, url=https://h5.medsci.cn/topic?id=9357, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=79142, tagList=[TagDto(tagId=79142, tagName=iclaprim)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2069325, encodeId=27dc2069325b9, content=<a href='/topic/show?id=e514935e88' target=_blank style='color:#2F92EE;'>#iclaprim#</a>, objectTitle=Iclaprim不會(huì)在ABSSSI患者中引起高鉀血癥, objectType=article, longId=180593, objectId=b5f9180593b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5f9180593b8, replyNumber=0, likeNumber=91, createdTime=2020-06-21, rootId=0, userName=yilong5287542, userId=87f580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5f9180593b8, moduleTitle=Iclaprim不會(huì)在ABSSSI患者中引起高鉀血癥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b5f9180593b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2069324, encodeId=11dd206932444, content=<a href='/topic/show?id=e514935e88' target=_blank style='color:#2F92EE;'>#iclaprim#</a>, objectTitle=Motif Bio的新型抗生素iclaprim獲得美國(guó)優(yōu)先審查, objectType=article, longId=146657, objectId=966d14665ef3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=966d14665ef3, replyNumber=0, likeNumber=86, createdTime=2018-11-12, rootId=0, userName=yilong5287542, userId=87f580, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=966d14665ef3, moduleTitle=Motif Bio的新型抗生素iclaprim獲得美國(guó)優(yōu)先審查, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=966d14665ef3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
